MANNIX CONSOLACION: Open Payments
NPI 1023582376 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$756 in 42 payments from 11 companies in 2025. Trend: 2023 $1,583 · 2024 $1,868 · 2025 $756
Food & beverage: $684Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $276 |
| ABBVIE INC. | 6 | $140 |
| Galderma Laboratories, L.P. | 4 | $64 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| PFIZER INC. | 2 | $33 |
| Amgen Inc. | 2 | $32 |
| Organon LLC | 3 | $29 |
| KYOWA KIRIN, INC. | 1 | $29 |
| Almirall LLC | 1 | $22 |
Products named: TREMFYA, SKYRIZI, NEMLUVIO, LIBTAYO, COSENTYX, CIBINQO, OTEZLA, POTELIGEO.
Industry payments across AZ — which companies pay providers there.
